Department of Public Health Programmes, Cancer Screening, 53198Randers Regional Hospital, Randers, Denmark.
Department of Clinical Medicine, 1006Aarhus University, Aarhus, Denmark.
J Med Screen. 2022 Dec;29(4):241-248. doi: 10.1177/09691413221102212. Epub 2022 May 29.
Evidence of reduction in colorectal cancer (CRC) mortality following CRC screening based on the faecal immunochemical test (FIT) is insufficient. This study aimed to analyse if CRC mortality was reduced after implementing FIT-based screening.
The Danish national CRC screening programme.
This nationwide cohort study included residents aged 50-71 years invited to the prevalence round of the screening programme. Invitation order was decided by randomising on birth month; the first two birth months to be invited were classified as invited and the five last were classified as not-yet-invited and given a pseudo invitation data. Follow-up was from (pseudo)invitation date until 31 December 2017, emigration or death. Relative risk (RR) of CRC death was calculated with 95% confidence intervals (CIs).
A total of 897,812 residents were included (29% invited and 71% not-yet-invited). The median follow-up was 3.3 years. The RR of CRC death at end of follow-up was 0.83 (95% CI 0.66; 1.03) among those invited to screening compared with those not yet invited. For men aged 60-71 years, this RR was 0.68 (95% CI 0.49; 0.94). For those participating in screening compared with a similar group of not-yet-invited residents, the RR was 0.71 (95% CI 0.46-1.08). For male participants aged 60-71 years, this RR was 0.49 (95% CI 0.27-0.89). For women and men aged 50-59 years, RRs were small and statistically non-significant.
This nationwide study showed that even within a median follow-up of only 3.3 years, implementing FIT-based CRC screening reduced CRC mortality among older men.
基于粪便免疫化学试验(FIT)的结直肠癌(CRC)筛查降低 CRC 死亡率的证据不足。本研究旨在分析实施 FIT 筛查后 CRC 死亡率是否降低。
丹麦全国性 CRC 筛查计划。
本全国性队列研究纳入了受邀参加筛查计划初筛轮次的 50-71 岁居民。邀请顺序通过按出生月份随机化确定;前两个月受邀的被分类为受邀,后五个月受邀的被分类为尚未受邀,并提供虚假邀请数据。随访从(虚假)邀请日期开始至 2017 年 12 月 31 日、移民或死亡。使用 95%置信区间(CI)计算 CRC 死亡的相对风险(RR)。
共纳入 897812 名居民(29%受邀,71%尚未受邀)。中位随访时间为 3.3 年。与尚未受邀者相比,受邀参加筛查者在随访结束时 CRC 死亡的 RR 为 0.83(95%CI 0.66;1.03)。对于 60-71 岁的男性,该 RR 为 0.68(95%CI 0.49;0.94)。与未受邀参加筛查的相似人群相比,参加筛查者的 RR 为 0.71(95%CI 0.46-1.08)。对于 60-71 岁的男性参与者,该 RR 为 0.49(95%CI 0.27-0.89)。对于 50-59 岁的女性和男性,RR 较小且无统计学意义。
本全国性研究表明,即使中位随访时间仅为 3.3 年,基于 FIT 的 CRC 筛查也能降低老年男性的 CRC 死亡率。